|
|
O-902 / O-902-1ML updated item number format
Oxazepam
1.0 mg/mL in Methanol | Certified Reference Material
|
A Certified Spiking Solution® used as a starting material in calibrators and controls for GC/MS or LC/MS testing applications in pain prescription monitoring, clinical toxicology, or forensic analysis. Oxazepam is a benzodiazepine drug used to treat anxiety and insomnia and to control the symptoms of alcohol withdrawal.
|
|
|
|
Concentration:
|
1.0 mg/mL
|
Solvent:
|
Methanol
|
Unit Size:
|
1 mL/ampoule
|
CAS Number:
|
604-75-1
|
Chemical Formula:
|
C15H11ClN2O2
|
Molecular Weight:
|
286.71
|
Certificate of Analysis:
|
|
US List Price:
|
|
|
|
Regulatory Control ▶ USDEA exempt chemical preparation - no USDEA registration or paperwork required ▶ Canada Test Kit Registration # 61-1430 - no Health Canada import authorization required
read more about ordering regulated substances
UN Number, Class, PG 1230, 3, II
Safety Data Sheet
HS Code
3822.90.0000
▶ Accelerated Stability Studies by High Performance Liquid Chromatography | Greg Serna, Tamara Tarbox, Isil Dilek, Cerilliant, 2012
|
▶ Automated Hydrolysis, DPX Extraction and LC/MS/MS Analysis of Pain Management Drugs from Urine | Fred D.Foster, John R. Stuff, Edward A.Pfannkoch, GERSTEL, 2014
|
▶ High Throughput Screening and confirmation of 41 Pain Panel Drugs in Oral Fluid by an Integrated On-Line Extraction UHPLC-MS/MS System | Louis Maljers, Zicheng Yang, Bruker Daltonics Inc, 2016
|
▶ LC/MS (TOF) Analysis of Drugs and Their Glucuronide Metabolites on Titan™ C18 after Solid Phase Extraction (SPE) using Supel™-Select SCX, ß-Glucuronidase Enzyme Digestion | Sigma-Aldrich®, 2014
|
▶ Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples | Robert M. Sears, Toxicology Technical Leader , Kenneth Lewis, CEO , and Kim Gamble, President, ITSP Solutions, INC., 2014
|
▶ Proof of Concept/Comparison of Automated SPE/HPLC/MS/MS Methods to Traditional Immunoassay with MS Confirmation in Death Investigation Cases | Robert M. Sears, Wendy C. Bell , Kenneth C. Lewis, Thurman L. Allsup and Kim Gamble, ITSP Solutions, INC., 2014
|
▶ Testing and Quantitation of Benzodiazepines in Urine and Serum by LC-TOF | Sharanya Reddy, Leslie Sullivan, George Perkins, PerkinElmer Inc., 2014
|
▶ UHPLC/MS Analysis of Benzodiazepines and Glucuronide Metabolites on Titan™ C18 | Sigma-Aldrich®, 2014
|
▶ UHPLC/MS Analysis of Diazepam and Metabolites on Titan™ C18, Comparison of Flow Rate and Column Length | Sigma-Aldrich®, 2014
|
▶ UHPLC/MS/MS Analysis of Benzodiazepines and Glucuronide Metabolites in Urine on Titan™ C18 after SPE using Supel™-Select HLB, ß-Glucuronidase Enzyme Digestion | Sigma-Aldrich®, 2014
|
▶ Using UHPLC/MS (TOF) for Detection of Drugs and Metabolites in Urine following Optimized Enzymatic Hydrolysis Conditions | Sigma-Aldrich®, 2015
|
|
|
|
|